Mode VC

Kevin Slawin, MD

Founder & Managing Partner atRapha Capital ManagementMiami
LinkedIn Rapha Capital Management websiteFirm profile

Kevin Slawin, MD, is founder and managing partner of Rapha Capital Management. He founded Bellicum Pharmaceuticals and performed robotic prostatectomy with the da Vinci System in 2001. He studied at Columbia University and Baylor College of Medicine.

What Kevin can write

Writes checks of$250K to $30M
Comes in atSeed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Rapha Capital Management writes $250K to $30M checks, larger than 33% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Rapha Capital Management.

Career

  1. Baylor College of Medicine · Director of The Baylor Prostate Center
    1994
  2. Baylor College of Medicine · Dan Duncan Family Professor in Prostate Cancer and Prostatic Diseases
    2003
  3. Bellicum Pharmaceuticals, Inc. · Founder
    2004
  4. AsclepiX Therapeutics, Inc. · Board member and interim CEO
    2020
  5. Rapha Capital Management, LLC · Founder and Managing Partner
    Now
  6. Texas Medical Center
    2001
  7. Bellicum Pharmaceuticals, Inc.
    2004

Companies founded

Rapha Capital Management, LLCBellicum Pharmaceuticals, Inc.Ponce Therapeutics, Inc.DELiver Therapeutics, Inc.

Investments named in public bios

3DBio Therapeutics, Inc.FIZE Medical, Inc.Demeetra AgBio, Inc.Imagin Medical, Inc.AsclepiX Therapeutics, Inc.

Focus

oncologyt cellsimmunotherapyhealthcare technologiesbiotechnology

Education

Columbia University, Bachelor of Arts degree in BiochemistryColumbia College of Physicians and Surgeons, medical degree

Partners like Kevin

At firms with a similar stage, sector and check size.

Jamie RutledgeGeneral Partner, Bluelake
Ann DeWitt
Ann DeWittGeneral Partner, The Engine
Aryeh GanzManaging Partner, Cornucopian Capital
Shaun A. KirkpatrickPresident, Biotechnologies, Research Corporation Technologies
Jack W. Lasersohn
Jack W. LasersohnGeneral Partner, The Vertical Group
Brad Corona
Brad CoronaManaging Director, Vertical Venture Partners

Alert me when Rapha Capital Management is active

One email when Kevin's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Kevin Slawin, MD?

Kevin Slawin, MD, is founder and managing partner of Rapha Capital Management. He founded Bellicum Pharmaceuticals and performed robotic prostatectomy with the da Vinci System in 2001. He studied at Columbia University and Baylor College of Medicine.

How much does Kevin Slawin, MD invest?

Kevin Slawin, MD invests through Rapha Capital Management, which writes checks of $250K to $30M at seed, series a, series b.

How do I pitch Kevin Slawin, MD?

A warm intro from a founder Rapha Capital Management backed works best. A short LinkedIn note with one line on traction is the next best route.

What did Kevin Slawin, MD do before Rapha Capital Management?

Director of The Baylor Prostate Center at Baylor College of Medicine; Dan Duncan Family Professor in Prostate Cancer and Prostatic Diseases at Baylor College of Medicine; Founder at Bellicum Pharmaceuticals, Inc.; Board member and interim CEO at AsclepiX Therapeutics, Inc.; Texas Medical Center; Bellicum Pharmaceuticals, Inc..

Last updated 2026-10-15. Is this you? Ask for a correction.